Doctor profile · Federal record

Dr. Vishnu Priya Mallipeddi, M.B.B.S

Cardiovascular Disease Physician (CMS: Cardiovascular Disease (Cardiology)) · Reidsville, NC

  • NPI 1386175008
  • Accepts Medicare
  • MIPS 82.7 / 100 · 2023
  • 13 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
618 S Main St
Reidsville, NC 273205020
(336) 951-4823
fax (336) 832-3201

Credentials & registration

NPPES · NUCC
NPI registered
March 2017 — 9 yrs on file
Profile last updated
October 22, 2024
Year of graduation
2013 — 13 yrs since
Specialty taxonomy
207RC0000X — NUCC code
State license (1)
North Carolina #2023-01584

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1386175008. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
162
Distinct HCPCS
7
Medicare allowed
$7,511
HCPCS Description Services Patients Avg allowed
93793 Anticoagulant management of patient taking warfarin 59 41 $11
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 26 16 $75
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function 19 19 $65
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only 18 18 $8
99204 New patient office or other outpatient visit, 45-59 minutes 14 14 $127
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only 13 13 $8
99204 New patient office or other outpatient visit, 45-59 minutes 13 13 $127

In context: peer comparison

Among 3 peers in this city , average services per provider: 82. This provider delivers 2.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$554
Transactions
28
Manufacturers
9
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 12 $180.91
Novo Nordisk Inc 6 $110.13
SCPHARMACEUTICALS INC. 2 $71.93
iRhythm Technologies, Inc. 2 $62.18
Amgen Inc. 2 $38.39
Boston Scientific Corporation 1 $34.11
Janssen Pharmaceuticals, Inc 1 $20.81
Boehringer Ingelheim Pharmaceuticals, Inc. 1 $18.78
PFIZER INC. 1 $16.87

By nature of payment

Food and Beverage
$554

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
270
Patients
151
Total drug cost
$18,383
Drug Type Claims Patients Total cost
Nitroglycerin Generic 47 37 $803
Metoprolol Tartrate Generic 44 31 $192
Furosemide Generic 29 18 $139
Atorvastatin Calcium Generic 26 13 $309
Amlodipine Besylate Generic 24 15 $137
Isosorbide Mononitrate Er (Isosorbide Mononitrate) Brand 20 12 $394
Lisinopril Generic 17 0 $141
Rosuvastatin Calcium Generic 16 14 $273
Ezetimibe Generic 13 11 $330
Metoprolol Succinate Generic 12 0 $175

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Vishnu Priya Mallipeddi's medical specialty?
Dr. Vishnu Priya Mallipeddi practices Cardiovascular Disease Physician in Reidsville, NC.
Where does Dr. Vishnu Priya Mallipeddi practice?
Dr. Vishnu Priya Mallipeddi practices at 618 S Main St, Reidsville, NC 273205020. Office phone: 3369514823.
What is Dr. Vishnu Priya Mallipeddi's NPI?
Dr. Vishnu Priya Mallipeddi's National Provider Identifier (NPI) is 1386175008, issued by NPPES.
Does Dr. Vishnu Priya Mallipeddi accept Medicare assignment?
Yes. Dr. Vishnu Priya Mallipeddi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Vishnu Priya Mallipeddi commonly perform?
Top Medicare-reported procedures in 2023: Anticoagulant management of patient taking warfarin (HCPCS 93793); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS 93306). Source: CMS Medicare Physician & Other Practitioners file.